论文部分内容阅读
最近,卫生部审批了一些药品新产品,这些药品新产品在目前看来都是疗效較好的,有些是疾病治疗中较为缺乏的药物。現将其中的两种加兰他敏及安宫黄体酮根据临床試驗資料簡单介紹如下。
Recently, the Ministry of Health approved a number of new drug products that appear to be of relatively good efficacy to date and some of which are relatively lacking in the treatment of diseases. Now one of the two galantamine and Annong progesterone based on clinical trial data are briefly described below.